References
- CDC. Meningococcal disease [Online]. 2017. https://www.cdc.gov/meningococcal/index.html.
- CDC. Immunology and vaccine preventable disease. 2015. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/mening.pdf.
- Manchanda V, Gupta S, Bhalla P. Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention. Indian J Med Microbiol. 2006;24(1):7–19. doi:10.4103/0255-0857.19888.
- Sanofi Pasteur. Prescribing information [Internet]. 2019 [cited 2020 Feb 8]. https://www.vaccineshoppe.com/image.cfm?pi=589-05&image_type=product_pdf.
- GSK Vaccines, Srl. Menveo Package Insert [Internet]. FDA. 2019 [cited 2020 Feb 8]. https://www.fda.gov/media/78514/download.
- MIMS. Meningitec [Internet]. NPS MedicineWise. 2014 [cited 2020 Feb 8]. https://www.nps.org.au/assets/medicines/e8beecc7-8566-4425-88ca-a53300ff36eb.pdf.
- GSK. Menjugate [Internet]. HPRA. 2017 [cited 2020 Feb 8]. https://www.hpra.ie/docs/default-source/vaccine-pils/menjugate-pil.pdf?sfvrsn=8.
- Pfizer Canada, Inc. NeisVac-C Vaccine [Internet]. Pfizer. 2019 [cited 2020 Feb 8]. https://www.pfizer.ca/sites/default/files/201907/NeisVac-C_PM_220376_24May2019_E.pdf.
- GSK. Menitorix [Internet]. GlaxoSmithKline Australia. 2018 [cited 2020 Feb 8]. https://au.gsk.com/media/404875/menitorix_pi_007_approved.pdf.
- Pfizer. NIMENRIX (Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine) [Internet]. Pfizer Medical Information. 2020 [cited 2020 Feb 8]. https://www.pfizermedicalinformation.ca/en-ca/nimenrix#.
- GlaxoSmithKline. MenHibrix [Internet]. FDA. 2018 [cited 2020 Feb 8]. https://www.fda.gov/media/83688/download.
- Kulkarni PS, Socquet M, Jadhav SS, Kapre SV, LaForce FM, Poonawalla CS. Challenges and opportunities while developing a group a meningococcal conjugate vaccine within a product development partnership: a manufacturer’s perspective from the serum institute of India. Clin Infect Dis. 2015;61(suppl_5):S483–S8. doi:10.1093/cid/civ500.
- LaForce FM, Okwo-Bele J-M. Eliminating epidemic group a meningococcal meningitis in africa through a new vaccine. Health Aff (Millwood). 2011;30(6):1049–1057. doi:10.1377/hlthaff.2011.0328.
- Sanofi Pasteur. 276 Menomune® – A/C/Y/W-135 [Internet]. FDA. 2016 [cited 2020 Feb 8]. http://fda.gov/media/83562/download.
- GlaxoSmithKline. Bexsero [Internet]. GSK for US Healthcare Professionals. 2019 [cited 2020 Feb 8]. https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Bexsero/pdf/BEXSERO.PDF.
- Pfizer. Trumenba [Internet]. Pfizer. 2019 [cited 2020 Feb 8]. http://labeling.pfizer.com/ShowLabeling.aspx?id=1796.
- UNICEF. Meningococcal vaccines: market & supply update. 2015. https://www.unicef.org/supply/files/Meningitis_Vaccine_Market_Supply_Update.pdf.
- ECDC. Factsheet about meningococcal disease. 2019. https://www.ecdc.europa.eu/en/meningococcal-disease/factsheet.
- Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol Clifton NJ. 2012;799:1–20.
- CDC. Clinical Information Meningococcal Disease: Technical and Clinical Information. 2019. https://www.cdc.gov/meningococcal/clinical-info.html.
- Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1–20. doi:10.1007/978-1-61779-346-2_1.
- WHO. Meningococcal disease. 2018. http://www.who.int/biologicals/vaccines/Meningococcal_Meningitis/en/.
- Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins MJ. Risk factors for meningococcal disease in college students. JAMA. 2001;286(6):688–693. doi:10.1001/jama.286.6.688.
- WHO. Meningococcal meningitis. 2018. http://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis.
- England PH. Returning students urged to get vaccinated against deadly infections. 2017. https://www.gov.uk/government/news/returning-students-urged-to-get-vaccinated-against-deadly-infections.
- Borrow R, Alarcón P, Carlos J, et al. The global meningococcal initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16(4):313–328. doi:10.1080/14760584.2017.1258308.
- Acevedo R, Bai X, Borrow R, et al. The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18(1):15–30. doi:10.1080/14760584.2019.1557520.
- CDC. Chapter 8: meningococcal disease. 2019. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html.
- Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States,1998–2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184–191. doi:10.1086/649209.
- Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis. 1999;180(6):1894–1901. doi:10.1086/315158.
- Olbrich KJ, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–438. doi:10.1007/s40121-018-0213-2.
- Davis KL, Bell TJ, Miller JM, Misurski DA, Bapat B. Hospital costs, length of stay and mortality associated with childhood, adolescent and young Adult meningococcal disease in the US. Appl Health Econ Health Policy. 2011;9(3):197–207.
- Ortega-Sanchez IR, Meltzer MI, Shepard C, et al. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis. 2008;46(1):1–13. doi:10.1086/524041.
- Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC. The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review. Pharmacoeconomics. 2013;31(7):563–576. doi:10.1007/s40273-013-0057-2.
- England PH. Guidance for public health management of meningococcal disease in the UK Updated August 2019. 2019. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/829326/PHE_meningo_disease_guideline.pdf.
- CDC. Immunization schedules. [Online] CDC. 2019. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.
- Canada G. Provincial and territorial routine and catch-up vaccination schedule for infants and children in Canada. 2019. https://www.canada.ca/en/public-health/services/provincial-territorial-immunization-information/provincial-territorial-routine-vaccination-programs-infants-children.html.
- NHS. Men ACWY vaccine. 2017. http://www.nhs.uk/conditions/vaccinations/pages/men-acwy-vaccine.aspx.
- Butler KM. Meningococcal meningitis prevention programs for college students: a review of the literature. Worldviews Evid Based Nurs. 2006;3(4):185–193. doi:10.1111/j.1741-6787.2006.00069.x.
- Withers BG, Craig SC. The historical impact of preventive medicine in war. Vol. 1. Walter Reed Army Medical Center, Washington, DC: Office of the Surgeon General, Department of the Army, United States of America; 2003:p. 46.
- CDC. Meningococcal disease and college students. 2000. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4907a2.htm.
- Castel AD, Reed G, Davenport MG, Harrison LH, Blythe D. College and university compliance with a required meningococcal vaccination law. J Am Coll Health. 2007;56(2):119–127. doi:10.3200/JACH.56.2.119-128.
- Team E. EndNote. 2016.
- JBI. Checklist for analytical cross-sectional studies. 2016. https://joannabriggs.org/research/critical-appraisal-tools.html.
- CRD. Systematic reviews. 2009. https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf.
- Manager R. Review Manager. 2014.
- MacDougall DM, Langley JM, Li L, et al. Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program. Vaccine. 2017;35(18):2520–2530. doi:10.1016/j.vaccine.2017.02.011.
- Langley JM, MacDougall DM, Halperin BA, et al. Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: a Canadian Immunization Research Network study. Vaccine. 2016;34(34):4046–4049. doi:10.1016/j.vaccine.2016.06.025.
- Turner DPJ, Oldfield NJ, Bayliss CD. University vaccine campaign increases meningococcal ACWY vaccine coverage. Public Health. 2017;145:1–3. doi:10.1016/j.puhe.2016.12.010.
- Fiorito TM, Bornschein S, Mihalakos A, et al. Rapid response to a college outbreak of meningococcal serogroup B disease: Nation’s first widespread use of bivalent rLP2086 vaccine. J Am Coll Health. 2017;65(4):294–296. doi:10.1080/07448481.2017.1285772.
- Roberts CL, Roome A, Algert CS, et al. A meningococcal vaccination campaign on a university campus: vaccination rates and factors in nonparticipation. Am J Public Health. 1996;86(8):1155–1158. doi:10.2105/ajph.86.8_pt_1.1155.
- McNamara LA, Shumate AM, Johnsen P, et al. First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics. 2015;135(5):798–804. doi:10.1542/peds.2014-4015.
- Basta NE, Mahmoud AAF, Wolfson J, et al. Immunogenicity of a meningococcal b vaccine during a university outbreak. N Engl J Med. 2016;375(3):220–228. doi:10.1056/NEJMoa1514866.
- McNamara LA, Thomas JD, MacNeil J, et al. Meningococcal carriage following a vaccination campaign with MenB-4C and MenB-FHbp in response to a university serogroup B meningococcal disease outbreak-Oregon, 2015–2016. J Infect Dis. 2017;216(9):1130–1140. doi:10.1093/infdis/jix446.
- Fisher EA, Poissant T, Luedtke P, Leman R, Young C, Cieslak P. Evaluation of mass vaccination clinics in response to a serogroup B meningococcal disease outbreak at a large, public university-Oregon, 2015. J Adolesc Health. 2018;63(2):151–156. Augdoi:10.1016/j.jadohealth.2018.03.018.
- Paneth N, Kort EJ, Jurczak D, et al. Predictors of vaccination rates during a mass meningococcal vaccination program on a college campus. J Am Coll Health. 2000;49(1):7–11. doi:10.1080/07448480009596276.
- Breakwell L, Vogt TM, Fleming D, et al. Understanding factors affecting university: a students' decision to receive an unlicensed serogroup B meningococcal vaccine. J Adolesc Health. 2016;59(4):457–464. doi:10.1016/j.jadohealth.2016.06.004.
- Ritscher AM, Ranum N, Malak JD, et al. Meningococcal serogroup B outbreak response University of Wisconsin-Madison. J Am Coll Health. 2019;67(3):191–196. doi:10.1080/07448481.2018.1469502.
- Edmunds MR, Davidson JE, Wood AL, Raichura V. Few university students from overseas have been vaccinated against meningococcal infection. BMJ. 2001;322(7278):102. doi:10.1136/bmj.322.7278.102.
- Thirlaway K, Lukman H. Meningitis C vaccine uptake by British undergraduates. Commun Dis Public Health. 2003;6(2):157–160.
- D’Heilly S, Ehlinger E, Nichol K. Predictors of meningococcal vaccination among university students. J Am Coll Health. 2006;55(3):169–173. doi:10.3200/JACH.55.3.169-173.
- Huang H-L, Cheng S-Y, Lee L-T, et al. On the trail of preventing meningococcal disease: a survey of students planning to travel to the United States. J Travel Med. 2013;20(4):243–246. doi:10.1111/jtm.12038.
- Mading C, Jacob C, Munch C, Lindeman K, Klewer J, Kugler J. Vaccination coverage among students from a German health care college. Am J Infect Control. 2015;43(2):191–194. doi:10.1016/j.ajic.2014.10.019.
- Moore PJA, Millar BC, Moore JE. Meningococcal ACWY vaccine uptake and awareness among student freshers enrolled at Northern Ireland universities. Int J Adolesc Med Health. 2017;18(32):28099125.
- Trayner KMA, Cameron JC, Anderson N. Meningococcal ACWY (MenACWY) vaccine uptake, and barriers and motivations towards vaccination, in undergraduate students: a mixed-methods study. Lancet. 2017;89:6.
- Blagden S, Seddon D, Hungerford D, Stanistreet D. Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: a cross-sectional study. Plos One. 2017;12(8):e0181817. 2doi:10.1371/journal.pone.0181817.
- Limaye V, Limaye D, Fortwengel G. A study to assess the vaccination coverage of university students in Mumbai, India. Curr Ther Res. 2016;78:S3. doi:10.1016/j.curtheres.2016.05.007.
- Fiorito TM, Baird GL, Alexander-Scott N, et al. Adverse events following vaccination with bivalent rLP2086 (Trumenba®): an observational, longitudinal study during a college outbreak and a systematic review. Pediatr Infect Dis J. 2018;37(1):e13–e19. Jandoi:10.1097/INF.0000000000001742.
- Moore PJA, Millar BC, Moore JE. Meningococcal ACWY vaccine uptake and awareness among student freshers enrolled at Northern Ireland universities. Int J Adolesc Med Health. 2017:32(1):0087. http://offcampus.lib.washington.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=28099125&site=ehost-live.
- Dubé E, Gagnon D, Hamel D, et al. Parents' and adolescents' willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec). Can J Infect Dis Med Microbiol. 2015;26(3):163–167. doi:10.1155/2015/732464.
- Douglas-Gabriel D. Freshman residency rules sometimes force students to pay prohibitive costs. 2015. https://www.washingtonpost.com/local/education/freshman-residency-rules-sometimes-force-students-to-pay-prohibitive-costs/2015/09/29/4693aed6-63b5-11e5-b38e-06883aacba64_story.html.
- Jepsen P, Johnsen SP, Gillman MW, Sorensen HT. Interpretation of observational studies. Heart. 2004;90(8):956–960. doi:10.1136/hrt.2003.017269.